Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Rp1l1em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Rp1l1em1/Cya

Common Name
Rp1l1-KO
Product ID
S-KO-08815
Backgroud
C57BL/6JCya
Strain ID
KOCMP-271209-Rp1l1-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Rp1l1-KO Mouse (Catalog S-KO-08815) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Rp1l1-KO
Strain ID
KOCMP-271209-Rp1l1-B6J-VA
Gene Name
Rp1l1
Product ID
S-KO-08815
Gene Alias
Dcdc4, Rp1hl1
Background
C57BL/6JCya
Gene Full Name
retinitis pigmentosa 1 homolog like 1
Modification
Conventional knockout
NCBI ID
271209 (Mouse)
Phenotype
MGI:2384303
Chromosome
Chr 14 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000058229
NCBI Transcript ID
NM_146246
Target Region
Exon 3
Size of Effective Region
~0.1 kb
Overview of Gene Research
Rp1l1, or Retinitis pigmentosa 1-like 1, is a component of the photoreceptor cilium. Although its exact function remains unknown, it is crucial for photoreceptor biology. The gene is associated with pathways related to photoreceptor development and maintenance, and its importance lies in preventing photoreceptor-related diseases [1,2]. Genetic models, such as gene knockout (KO) or conditional knockout (CKO) mouse models, could potentially be valuable for further functional studies of Rp1l1 in vivo.

Pathogenic variants in Rp1l1 lead to photoreceptor diseases, including occult macular dystrophy (a cone degeneration) and retinitis pigmentosa (a rod disease) [1,2]. In a study of 1204 Japanese patients with retinitis pigmentosa, variants in Rp1l1 were among the six genes that caused the disease in a significant proportion of patients [3]. In a Chinese cohort of inherited eye diseases, Rp1l1 had a diagnostic yield of de novo mutations of 5.88% [4]. A case report described an Indian patient with a homozygous variant in Rp1l1, presenting with ill-defined foveal mottling, sub-foveal hyper-reflective deposits, and outer retinal layer disruption, diagnosed with Rp1L1 maculopathy [5]. Additionally, the RP1L1 rs3924612 polymorphism was associated with early age-related macular degeneration development in certain female and age groups [6]. In patients with macular and cone/cone-rod dystrophy, mutations in Rp1L1 were identified [7]. In RP1L1-associated occult macular dystrophy, there was predominantly a deterioration of L-and M-cone-driven function in the perifovea, while rod-driven functions were normal [8]. In Taiwanese families with inherited retinal degeneration, probands affected by Rp1L1 sought medical help earlier [9]. A Chinese family was identified with a maculopathy case caused by new recessive compound heterozygous variants of Rp1L1 [10].

In conclusion, Rp1l1 is essential for photoreceptor biology, and its malfunction is strongly associated with various photoreceptor-related diseases, such as retinitis pigmentosa, occult macular dystrophy, and maculopathy. Although no KO/CKO mouse model-specific findings were in the provided abstracts, the existing human-based genetic and clinical studies highlight the significance of Rp1l1 in maintaining normal photoreceptor function and the potential implications for understanding and treating these diseases.

References:
1. Noel, Nicole C L, MacDonald, Ian M. 2020. RP1L1 and inherited photoreceptor disease: A review. In Survey of ophthalmology, 65, 725-739. doi:10.1016/j.survophthal.2020.04.005. https://pubmed.ncbi.nlm.nih.gov/32360662/
2. Liu, Jiali, Hayden, Melvin R, Yang, Ying. 2024. Research progress of RP1L1 gene in disease. In Gene, 912, 148367. doi:10.1016/j.gene.2024.148367. https://pubmed.ncbi.nlm.nih.gov/38485037/
3. Koyanagi, Yoshito, Akiyama, Masato, Nishiguchi, Koji M, Kubo, Michiaki, Sonoda, Koh-Hei. 2019. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. In Journal of medical genetics, 56, 662-670. doi:10.1136/jmedgenet-2018-105691. https://pubmed.ncbi.nlm.nih.gov/31213501/
4. Li, Wei, He, Xiang-Dong, Yang, Zheng-Tao, Li, Jian-Kang, He, Wei. . De Novo Mutations Contributes Approximately 7% of Pathogenicity in Inherited Eye Diseases. In Investigative ophthalmology & visual science, 64, 5. doi:10.1167/iovs.64.2.5. https://pubmed.ncbi.nlm.nih.gov/36729443/
5. Manayath, George J, Rokdey, Mayur, Verghese, Shishir, Saravanan, V R, Narendran, Venkatapathy. 2021. An extended phenotype of RP1L1 maculopathy - case report. In Ophthalmic genetics, 43, 392-399. doi:10.1080/13816810.2021.2021426. https://pubmed.ncbi.nlm.nih.gov/34965838/
6. Daniute, Ginte, Vilkeviciute, Alvita, Gedvilaite, Greta, Kriauciuniene, Loresa, Liutkeviciene, Rasa. 2021. RP1L1 rs3924612 gene polymorphism and RP1L1 protein associations among patients with early age-related macular degeneration. In Ophthalmic genetics, 43, 164-171. doi:10.1080/13816810.2021.2010770. https://pubmed.ncbi.nlm.nih.gov/34865606/
7. Birtel, Johannes, Eisenberger, Tobias, Gliem, Martin, Bolz, Hanno J, Charbel Issa, Peter. 2018. Clinical and genetic characteristics of 251 consecutive patients with macular and cone/cone-rod dystrophy. In Scientific reports, 8, 4824. doi:10.1038/s41598-018-22096-0. https://pubmed.ncbi.nlm.nih.gov/29555955/
8. Huchzermeyer, Cord, Fars, Julien, Kremers, Jan, Stingl, Krunoslav, Stingl, Katarina. . Photoreceptor-Specific Temporal Contrast Sensitivities in RP1L1-Associated Occult Macular Dystrophy. In Investigative ophthalmology & visual science, 64, 33. doi:10.1167/iovs.64.7.33. https://pubmed.ncbi.nlm.nih.gov/37342031/
9. Chen, Ta-Ching, Huang, Ding-Siang, Lin, Chao-Wen, Hu, Fung-Rong, Chen, Pei-Lung. 2021. Genetic characteristics and epidemiology of inherited retinal degeneration in Taiwan. In NPJ genomic medicine, 6, 16. doi:10.1038/s41525-021-00180-1. https://pubmed.ncbi.nlm.nih.gov/33608557/
10. Cao, Wen-Chao, Chen, Qing-Shan, Gan, Run, Huang, Tao, Yan, Xiao-He. 2024. New recessive compound heterozygous variants of RP1L1 in RP1L1 maculopathy. In International journal of ophthalmology, 17, 107-112. doi:10.18240/ijo.2024.01.14. https://pubmed.ncbi.nlm.nih.gov/38239955/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research